Compounds > perindopril
Page last updated: 2024-09-02

perindopril and Bright Disease

perindopril has been researched along with Bright Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jakjovski, K; Labacevski, N; Petrusevska, G; Trojacanec, J; Trojacanec, P; Zafirov, D; Zdravkovski, P1
Amemiya, M; Ando, Y; Asano, Y; Honma, S; Iimura, O; Kusano, E; Muto, S; Tanba, K; Yanagiba, S1

Other Studies

2 other study(ies) available for perindopril and Bright Disease

ArticleYear
Perindopril treatment in streptozotocin induced diabetic nephropaty.
    Prilozi (Makedonska akademija na naukite i umetnostite. Oddelenie za medicinski nauki), 2013, Volume: 34, Issue:1

    Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Biomarkers; Blood Urea Nitrogen; Creatinine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Female; Glomerulonephritis; Hypertrophy; Kidney; Male; Perindopril; Rats, Wistar; Streptozocin; Time Factors

2013
[Additive antiproteinuric effect of angiotensin II receptor antagonist and angiotensin-converting enzyme inhibitor in patients with chronic glomerulonephritis].
    Nihon Jinzo Gakkai shi, 2003, Volume: 45, Issue:5

    Topics: Adult; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Biphenyl Compounds; Chronic Disease; Collagen Type IV; Drug Therapy, Combination; Female; Glomerulonephritis; Humans; Male; Perindopril; Proteinuria; Tetrazoles; Treatment Outcome

2003